3 days ago
IRON
AnalystsKristen KluskaKristen Kluska's Stock Forecasts
AnalystsKristen Kluska
Sectors:
Analyst Ranking
Top 2%
#74 out of 5069 analysts
Average Return
+31.2%
Win Rate
43%100 out of 231
Risk vs Reward
Poor
Good
Kristen Kluska's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Ocugen IncOCGN | +2,480.06% | $0.36 | $9.19 | 2020-10-09 - 2021-05-07 | Strong Buy |
Soleno Therapeutics IncSLNO | +901.02% | $4.89 | $48.95 | 2023-08-31 - 2024-08-30 | Strong Buy |
Celldex Therapeutics IncCLDX | +808.47% | $3.07 | $27.89 | 2020-02-21 - 2021-02-19 | Strong Buy |
Soleno Therapeutics IncSLNO | +779.14% | $4.89 | $42.99 | 2023-07-11 - 2024-07-10 | Strong Buy |
Uniqure NvQURE | +710.06% | $7.16 | $58.00 | 2024-11-06 - 2025-10-17 | Strong Buy |
Kristen Kluska Analyst Color
Get additional color on Kristen Kluska's coverage of popular stocks
25 days ago
QURE
3 months ago
ZVRA
7 months ago
SLNO
7 months ago
IRON
9 months ago
PTCT
10 months ago
QURE
a year ago
CAPR
a year ago
FOLD
a year ago
SRPT
a year ago
ADMA
a year ago
RARE
a year ago
ADMA
a year ago
RARE
a year ago
ADMA
2 years ago
SLNO
2 years ago
TSHA
2 years ago
IRON
2 years ago
CBAY
2 years ago
ETNB
3 years ago
ETNB
3 years ago
CBAY
3 years ago
ABEO
Kristen Kluska's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Disc Medicine IncIRON | 9 | Strong Buy | $153.00 | +70.11% | Maintains | 3 days ago |
Supernus Pharmaceuticals IncSUPN | 4 | Strong Buy | $63.00 | +25.57% | Maintains | 20 days ago |
Uniqure NvQURE | 7 | Strong Buy | $80.00 | +37.93% | Maintains | 25 days ago |
Ultragenyx Pharmaceutical IncRARE | 20 | Strong Buy | $105.00 | +221.74% | Reiterates | a month ago |
Ptc Therapeutics IncPTCT | 21 | Strong Buy | $118.00 | +78.92% | Reiterates | 2 months ago |
Monopar TherapeuticsMNPR | 2 | Strong Buy | $74.00 | -7.65% | Reiterates | 2 months ago |
Rigel Pharmaceuticals IncRIGL | 7 | Hold | $32.00 | +14.53% | Maintains | 2 months ago |
Eupraxia Pharmaceuticals IncEPRX | 1 | Strong Buy | $11.00 | +90.31% | Initiates Coverage On | 3 months ago |
Zevra Therapeutics IncZVRA | 3 | Strong Buy | $29.00 | +168.39% | Maintains | 3 months ago |
Solid Biosciences IncSLDB | 1 | Strong Buy | $16.00 | +172.11% | Assumes | 5 months ago |
Fulcrum Therapeutics IncFULC | 3 | Strong Buy | $10.00 | +11.23% | Upgrades | 5 months ago |
Capricor Therapeutics IncCAPR | 6 | Strong Buy | $30.00 | +380.00% | Reiterates | 5 months ago |
Sarepta Therapeutics IncSRPT | 16 | Strong Buy | $81.00 | +259.84% | Maintains | 5 months ago |
Taysha Gene Therapies IncTSHA | 16 | Strong Buy | $7.00 | +48.31% | Reiterates | 6 months ago |
Soleno Therapeutics IncSLNO | 6 | Strong Buy | $123.00 | +87.87% | Maintains | 7 months ago |
X4 Pharmaceuticals IncXFOR | 4 | Strong Buy | $90.00 | +2,930.30% | Reiterates | 7 months ago |
Mereo Biopharma Group PLCMREO | 10 | Strong Buy | $7.00 | +241.46% | Reiterates | 7 months ago |
Adma Biologics IncADMA | 9 | Strong Buy | $25.00 | +74.09% | Reiterates | 8 months ago |
Celldex Therapeutics IncCLDX | 15 | Strong Buy | $67.00 | +149.72% | Reiterates | 9 months ago |
Amicus Therapeutics IncFOLD | 6 | Strong Buy | $21.00 | +161.19% | Reiterates | 9 months ago |
89bio IncETNB | 13 | Strong Buy | $29.00 | +96.48% | Reiterates | 10 months ago |
Aquestive Therapeutics IncAQST | 1 | Strong Buy | $17.00 | +140.11% | Initiates Coverage On | 10 months ago |
Esperion Therapeutics IncESPR | 1 | Strong Buy | $8.00 | +190.91% | Initiates Coverage On | 10 months ago |
Codexis IncCDXS | 6 | Strong Buy | $11.00 | +315.09% | Reiterates | a year ago |
Abeona Therapeutics IncABEO | 8 | Strong Buy | $18.00 | +234.57% | Reiterates | a year ago |
Skye Bioscience IncSKYE | 8 | Strong Buy | $14.00 | N/A | Reiterates | a year ago |
Humacyte IncHUMA | 7 | Strong Buy | $13.00 | N/A | Reiterates | a year ago |
Actinium Pharmaceuticals IncATNM | 3 | Strong Buy | $21.00 | N/A | Reiterates | a year ago |
Cymabay Therapeutics IncCBAY | 6 | Hold | $32.50 | N/A | Downgrades | 2 years ago |
Lineage Cell Therapeutics IncLCTX | 3 | Strong Buy | $6.00 | N/A | Reiterates | 2 years ago |
Outlook Therapeutics IncOTLK | 2 | Hold | $20.00 | N/A | Downgrades | 2 years ago |
Alpha Tau Medical LtdDRTS | 2 | Strong Buy | $23.00 | N/A | Reiterates | 2 years ago |
Mustang Bio IncMBIO | 1 | Strong Buy | $900.00 | N/A | Reiterates | 2 years ago |
Opus Genetics IncIRD | 3 | Strong Buy | $17.00 | N/A | Reiterates | 2 years ago |
Durect CorpDRRX | 2 | Strong Buy | $41.00 | N/A | Maintains | 2 years ago |
Galecto IncGLTO | 1 | Strong Buy | $400.00 | N/A | Initiates Coverage On | 3 years ago |
Ibio IncIBIO | 3 | Hold | $85.00 | N/A | Downgrades | 3 years ago |
Sio Gene Therapies IncSIOX | 1 | Hold | $0.80 | N/A | Downgrades | 3 years ago |
Hepion Pharmaceuticals IncHEPA | 1 | Strong Buy | $3,500.00 | N/A | Initiates Coverage On | 4 years ago |
Ernexa Therapeutics IncERNA | 1 | Strong Buy | $9.00 | N/A | Initiates Coverage On | 4 years ago |
Evelo Biosciences IncEVLO | 1 | Strong Buy | $560.00 | N/A | Initiates Coverage On | 4 years ago |
Chemomab Therapeutics LtdCMMB | 1 | Strong Buy | $180.00 | N/A | Initiates Coverage On | 4 years ago |
Ocugen IncOCGN | 3 | Hold | $11.00 | N/A | Downgrades | 4 years ago |
Marker Therapeutics IncMRKR | 2 | Strong Buy | $60.00 | N/A | Initiates Coverage On | 5 years ago |
Evogene LtdEVGN | 1 | Strong Buy | $90.00 | N/A | Initiates Coverage On | 5 years ago |
Applied Genetic Technologies CorpAGTC | 1 | Strong Buy | $14.00 | N/A | Initiates Coverage On | 5 years ago |
Taiwan Liposome Company LtdTLC | 2 | Strong Buy | $10.00 | N/A | Reiterates | 6 years ago |
Galmed Pharmaceuticals LtdGLMD | 2 | Strong Buy | $2,520.00 | N/A | Assumes | 6 years ago |
Biomx IncPHGE | 1 | Strong Buy | $160.00 | N/A | Initiates Coverage On | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.